Developing FuturaLead, the world’s first intrathecal spinal cord stimulation (iSCS) lead, placed directly on the spinal cord surface, enabling superior efficacy and closed-loop neuromodulation via ECAP sensing.
Spinally is differentiated by its intrathecal spinal cord stimulation lead, which sits directly on the cord surface and aims to improve efficacy while enabling ECAP-based closed-loop control. This is a technically bold hardware innovation in a market otherwise dominated by incremental lead improvements.